News|Articles|January 3, 2026

5 Allergy Headlines You Missed in December 2025

Fact checked by: Victoria Johnson

December highlights: FDA approval of berotralstat for pediatric HAE, phase 3 RAPIDe-3 results, and allergy field spotlights in our This Year in Medicine series.

December 2025 capped a transformative year in allergy and immunology, with late-breaking regulatory decisions, pivotal trial results, and emerging clinical insights reinforcing the rapid pace of change across the field. This month in review highlights key developments shaping day-to-day practice, including new and forthcoming therapies for hereditary angioedema (HAE), advances in food allergy management, and data that further refine treatment selection and patient counseling.